Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:4.1.2.13 (
aldolase
)
3,461
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
In addition to its roles in sugar metabolism, fructose-1,6-bisphosphate
aldolase
(
aldolase
) has been implicated in cellular functions independent from these roles, termed "moonlighting functions." These moonlighting functions likely involve the known
aldolase
-actin interaction, as many proteins with which
aldolase
interacts are involved in actin-dependent processes. Specifically,
aldolase
interacts both in vitro and in cells with Wiskott-Aldrich Syndrome Protein (WASP), a protein involved in controlling actin dynamics, yet the function of this interaction remains unknown. Here, the effect of
aldolase
on WASP-dependent processes in vitro and in cells is investigated. Aldolase inhibits WASP/
Arp2
/3-dependent actin polymerization in vitro. In cells, knockdown of
aldolase
results in a decreased rate of cell motility and cell spreading, two WASP-dependent processes. Expression of exogenous
aldolase
rescues these defects. Whether these effects of
aldolase
on WASP-dependent processes were due to
aldolase
catalysis or moonlighting functions is tested using
aldolase
variants defective in either catalytic or actin-binding activity. While the actin-binding deficient
aldolase
variant is unable to inhibit actin polymerization in vitro and is unable to rescue cell motility defects in cells, the catalytically inactive
aldolase
is able to perform these functions, providing evidence that
aldolase
moonlighting plays a role in WASP-mediated processes.
...
PMID:Aldolase sequesters WASP and affects WASP/Arp2/3-stimulated actin dynamics. 2349 10